Veterinary Medicines

REFORDOG 40 mg/200 mg spot-on solution for dogs over 1.5 kg up to 4 kg

Authorised
  • Imidacloprid
  • Permethrin (40:60)
Download as PDF

Product identification

Medicine name:
REFORDOG 40 mg/200 mg spot-on solution for dogs over 1.5 kg up to 4 kg
REFORDOG 40 mg/200 mg soluzione spot-on per cani
Active substance:
  • Imidacloprid
  • Permethrin (40:60)
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Imidacloprid
    40.00
    milligram(s)
    /
    1.00
    Pipette
  • Permethrin (40:60)
    200.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Cardboard box containing 1 pipette of 0.4 ml with pouch
  • Cardboard box containing 1 pipette of 0.4 ml without pouch
  • Cardboard box containing 2 pipettes of 0.4 ml with pouch
  • Cardboard box containing 2 pipettes of 0.4 ml without pouch
  • Cardboard box containing 3 pipettes of 0.4 ml with pouch
  • Cardboard box containing 3 pipettes of 0.4 ml without pouch
  • Cardboard box containing 4 pipettes of 0.4 ml with pouch
  • Cardboard box containing 4 pipettes of 0.4 ml without pouch
  • Cardboard box containing 6 pipettes of 0.4 ml with pouch
  • Cardboard box containing 6 pipettes of 0.4 ml without pouch
  • Cardboard box containing 24 pipettes of 0.4 ml without pouch
  • Cardboard box containing 24 pipettes of 0.4 ml with pouch

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetpharma Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ab7 Sante
Responsible authority:
  • European Medicines Agency
Authorisation number:
  • 105649
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0666/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."